Expression of the bacterial gene in gallbladder carcinoma tissue and bile

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 1, 2004, Pages 133-135

  Lu, Yun ^a   Zhang, Bing Yuan ^a   Shi, Jing Sen ^b   Wu, Li Qun ^a  

^a QINGDAO UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bacteria; Expression; Gallbladder carcinoma; Gene; Relative bile; Tissue

Indexed keywords

BACTERIAL DNA; DNA FRAGMENT; PARAFFIN; PRIMER DNA; RNA 16S;

ADULT; AGED; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTEROIDES FRAGILIS; BASE PAIRING; BILE; CARCINOGENESIS; CHOLECYSTECTOMY; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; GALLBLADDER CARCINOMA; GALLBLADDER MUCOSA; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; KLEBSIELLA; MALE; POLYMERASE CHAIN REACTION; SURGICAL DRAINAGE; TISSUE SLICE;

ADOLESCENT; ADULT; AGED; BILE; BIOPSY, NEEDLE; CHOLECYSTECTOMY; CHOLECYSTITIS; CULTURE TECHNIQUES; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, BACTERIAL; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 1342265887     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Shi JS, Wang JS, Liu G, Yu YL, Lu Y, Jiao XY, et al. Early diagnosis of primary gallbladder carcinoma. Hepatobiliary Pancreat Dis Int 2002;1:273-275.
2. Tsuchiya T, Shimokawa I, Higami Y, Ohtani H, Shigeoka Y, Ohshima K, et al. Primary low-grade MALT lymphoma of the gallbladder. Pathol Int 2001;51:965-969.
3. Su WC, Chan KK, Lin XZ, Lin PW, Chow NH, Shin JS, et al. A clinical study of 130 patients with biliary tract cancers and periampullary tumors. Oncology 1996;53:488-493.
4. Kato H, Koyabu S, Aoki S, Tamai T, Sugawa M, Watanabe M, et al. An autopsy case of gallbladder cancer developing in a Japanese man with cerebrotendinous xanthomatosis: genetic analysis of the sterol 27-hydroxylase and p53 genes. Pathology 2003;35:141-144.
5. Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, et al. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol 2003;16:299-308.
6. Lu Y, Xiang TH, Shi JS, Sun Z. Bile anaerobic bacteria detection and antibiotic susceptibility in patients with gallstone. Hepatobiliary Pancreat Dis Int 2003;2:431-434.
7. Kohya N, Kitajima Y, Jiao W, Miyazaki K. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression. Int J Cancer 2003;104:44-53.
8. Wadler S, Yu B, Tan JY, Rozenblit A, Kaufiman H, Edelman M, et al. Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants. Clin Cancer Res 2003;9:33-43.
9. Kim YT, Kim J, Jang YH. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. Cancer Lett 2001;169:59-68.
10. Tazuma S, Kajiyama G. Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg 2001;386:224-229.
11. Kohya N, Kitajima Y, Kitahara K, Miyazaki K. Mutation analysis of K-ras and beta-catenin genes related to 06-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma. Int J Mol Med 2003;11:65-69.
12. Rashid A, Ueki T, Gao YT, Houhhan PS, Wallace C, Wang BS, et al. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res 2002;8:3156-3163.
13. Zhang W, Yue B, Wang GQ Serum and ascites levels of macrophage migration inhibitory factor, TNF-α and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat Dis Int 2002;1:577-580.
14. Feng HY, Shi YJ, WU CX. Mononuclear macrophages in pathogenesis of acute lung injury during acute obstructive cholangitis. Hepatobiliary Pancreat Dis Int 2002;1:587-591.
15. Takai S, Shiratori Y, Kanematsu M, Yamzaki K, Baiki T, Yasuka I, et al. Usefulness of MR imaging in the postsurgical monitoring of gallbladder cancer in a patient with bile duct cancer that developed 7 years after resection of mucinous adenocarcinoma of the gallbladder. J Gastroenterol 2001;36:787-789.
16. Tsuchida A, Itoi T, Aoki T, Kayanage K. Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review). Oncol Rep 2003;10:1693-1699.
17. Koda M, Yashima K, Kawaguchi K. Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma. Cancer Lett 2003;25:199:131-138.
18. Caca K, Feisthammel JI. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Int J Cancer 2002;97:481-488.
19. Kimura Y, Furuhata T, Mukaiya M, Kihara C, Kawakami M, Okita K, et al. Frequent beta-catenin alteration in gallbladder carcinomas. J Exp Clin Cancer Res 2003;22:321-328.
20. Nakayama K, Konno M, Kanzaki A. Allelotype analysis of gallbladder carcinoma associated with anomalous junction of pancreaticobiliary duct. Cancer Lett 2001;166:135-141.
21. Wistuba II, Ashfaq R. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Am J Pathol 2002;160:2073-2079.
22. Matsumoto Y, Fujii H, Itakura J. Recent advances in pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 2002;9: 45-54.
23. Tsuchiya T, Shimokawa I, Higami Y, Otani H, Komastsu T, Chiba T, et al. Primary low-grade MALT lymphoma of the gallbladder. Pathol Int 2001;51:965-969.
24. Rashid A, Gao YT, Bhakta S. Beta-catenin mutations in biliary tract cancers: a population-based study in China. Cancer Res 2001;61:3406-3409.
25. Ahrendt SA, Rashid A, Chow JT. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer. J Hepatobiliary Pancreat Surg 2000;7:426-431.
26. Otani K, Shimizu S, Chijiiwa K, Yamaguchi K, Noshiro H, Tanaka M. Immunohistochemical detection of 8-hydroxy-2′-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction. Eur J Gastroenterol Hepatol 2001; 13:1363-1369.
27. Saetta A, Lazaris AC, Michalopoulos NV. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients. Hepatogastroenterology 2001;48:1284-1288.
28. Kiguchi K, Carbajal S, Chan K, Beitran L, Ruffino L, Shen J, et al. Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. Cancer Res 2001;61:6971-6976.
29. Kashiwagi K, Ikeda H, Hirohashi Y. Analysis of a shared pancreatic cancer antigen recognized by an HLA-A * 2601-restricted cytotoxic T-lymphocyte clone. Pancreas 2003;26:E81-88.
30. Quan ZW, Wu K, Wang J. Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer. J Am Coll Surg 2001;193:380-383.
31. Mollenhauer J, Herbertz S, Helmke B, Kollender G, Krabes I, Madsen K, et al. Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res 2001;61:8880-8886.
32. Su WC, Shiesh SC, Liu HS. Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders. Dig Dis Sci 2001;46:1387-1392.
33. Wistuba II, Tang M, Maitra A. Genome-Aide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res 2001;61:3795-3800.
34. Nakano K, Todo T, Chijiiwa K. Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters. Mol Ther 2001;3:431-437.
35. Boudny V, Nakano S. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells. Anticancer Res 2003;23:7-12.
36. Tao KS, Lu YG, Wang T, Dou KF. Procedures for congenital choledochal cysts and curative effect analysis in adults. Hepatobiliary Pancreat Dis Int 2002;1:442-445.
37. Miyasaka K, Takata Y, Funakoshi A. Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism. J Gastroenterol 2002;37 ( Suppl 14):102-106.
38. Matsubara T, Sakurai Y, Zhi LZ. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 2002;9: 312-321.
39. Kim YW, Park YK, Yoon TY. Expression of the GLUT1 glucose transporter in gallbladder carcinomas. Hepatogastroenterology 2002;49:907-911.
40. Ku JL, Yoon KA, Kim IJ, Kim WH, Jang JY, Suh KS, et al. Establishment and characterisation of six human biliary tract cancer cell lines. Br J Cancer 2002;87:187-193.
41. Zhou YM, Li YM, Cao N, Feng Y, Zeng F. Significance of expression of epidermal growth factor (EGF) and its receptor (EGFR) in chronic cholecystitis and gallbladder carcinoma . Ai Zheng 2003;22:262-265.
42. Rashid A. Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am 2002;11:995-1009.
43. Matsuo K, Kuroki T, Kitaoka F, Tajima Y, Kanamatsu T. Loss of heterozygosity of chromosome 16q in gallbladder carcinoma. J Surg Res 2002;102:133-136.